NCT03228563 is a NA clinical trial of Probioics in Chronic Kidney Disease, sponsored by China Medical University Hospital.

Who is sponsoring NCT03228563?

NCT03228563 is sponsored by China Medical University Hospital.

What drugs are being tested in NCT03228563?

Interventions in NCT03228563: Probioics.

What condition does NCT03228563 study?

NCT03228563 studies Chronic Kidney Disease, Probiotics, Renal Function.

Is NCT03228563 still recruiting?

NCT03228563 is currently completed. Last updated 21 July 2022.

Last reviewed 2022-07-21 · How we verify

NCT03228563

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Probiotics on Chronic Kidney Disease

Completed NA Last updated 21 July 2022

What this trial tests

NA trial testing Probioics in Chronic Kidney Disease in 148 participants. Completed in 30 April 2022.

Timeline

23 May 2017

Primary endpoint
19 August 2021

30 April 2022

Quick facts

Lead sponsor	China Medical University Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	148
Start date	23 May 2017
Primary completion	19 August 2021
Estimated completion	30 April 2022
Sites	1 location across Taiwan

Drugs / interventions tested

Probioics

Conditions studied

Chronic Kidney Disease — all drugs for Chronic Kidney Disease →
Probiotics — all drugs for Probiotics →
Renal Function — all drugs for Renal Function →

Sponsor

China Medical University Hospital

Who can join

20 and older, any sex, with Chronic Kidney Disease or Probiotics. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Probiotics could attenuate renal function deterioration in CKD patients.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Uremic Toxins in the Progression of Chronic Kidney Disease and Cardiovascular Disease: Mechanisms and Therapeutic Targets.
Lim YJ, Sidor NA, Tonial NC, Che A, et al · · 2021 · cited 227× · PMID 33668632 · DOI 10.3390/toxins13020142
Effect of a Probiotic Combination in an Experimental Mouse Model and Clinical Patients With Chronic Kidney Disease: A Pilot Study.
Wang IK, Yen TH, Hsieh PS, Ho HH, et al · · 2021 · cited 27× · PMID 34136518 · DOI 10.3389/fnut.2021.661794

Verify or expand the search:

Other recruiting trials for Chronic Kidney Disease

Currently open trials in the same condition.

NCT07469540 — Effects of an Aerobic Exercise Program on Cardiovascular Risk in Patients With Chronic Kidney Disease or Rheumatoid Arth · NA · recruiting
NCT07169422 — Improving Kidney Care in Type 2 Diabetes: A Study of Pharmacist Prescribing Versus Usual Care · NA · recruiting
NCT07481526 — A Prospecitve Multicenter, Observational Registry Study · recruiting
NCT07450820 — OPTIMISE-CKD Study_Dapagliflozin Effectiveness in CKD · recruiting
NCT07107945 — A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease · Phase 3 · recruiting

Other China Medical University Hospital trials

Trials by the same sponsor.

NCT07525700 — The Effects of Combining Electronic Picture Books With RPG-Based Gamified Learning on Nursing Students' Motivation and L · NA · not yet recruiting
NCT07463391 — Chinese Classics Recitation Training in Subjective Cognitive Decline · NA · not yet recruiting
NCT07482189 — Effectiveness and Efficiency of an Upper Limb Active-Passive Exoskeleton Robot in Patients With Frozen Shoulder · NA · not yet recruiting
NCT07437144 — Exploring the Effects of Shangshou Daoyin Method on Improving Sleep Quality, Quality of Life, and TCM Constitution in Br · NA · not yet recruiting
NCT07232667 — Digital Technology for Active and Healthy Ageing in Taiwan · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03228563 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by China Medical University Hospital
Last refreshed: 21 July 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03228563.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing